Market Overview:
The US generic injectables market reached a value of US$ 16.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2027, exhibiting a CAGR of 10.21% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A generic injectable refers to a bioequivalent of the branded pharmaceutical needle with the same active ingredients and therapeutic effects. It has similar dosage, risks, side effects, consequences, performance, strengths, intended use, and route of administration. It is as safe and effective as the innovator drugs and used for rapidly transporting the drug into the body. It helps in the easy absorption of drugs into the body and reduces the frequency of dosage administration without affecting the effectiveness of the treatment. Besides this, it is cost-effective and does not require investments in testing, research and development (R&D), and promotional activities as compared to its branded counterparts. As a result, generic injectables are utilized in the treatment of various diseases, such as cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, and respiratory and cardiovascular disorders.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
US Generic Injectable Market Trends:
The growing geriatric population and the rising prevalence of chronic medical ailments, such as diabetes, cancer, and cardiovascular diseases, represent one of the key factors increasing the need for generic injectables in the US. In addition, the growing occurrence of lifestyle disorders due to changing dietary patterns and sedentary lifestyles of individuals is positively influencing the market. In line with this, various initiatives undertaken by the US government for providing support to key manufacturers and sellers are offering a favorable market outlook. This, in confluence with the low production cost of generic medicines, is contributing to the market growth. Furthermore, the expansion of offline pharmacies in the country, along with the easy availability of generic injectables via online pharmacies and the patent expiration of several branded injectables, are offering lucrative growth opportunities to generic injectables manufacturers. Additionally, drug shortages in the country, coupled with speedy approvals by the United States Food and Drug Administration (USFDA), are increasing the manufacturing of these injectables. Apart from this, rising investments by leading market players in research and development (R&D) activities for developing advanced generic injectables are creating a positive market outlook. Moreover, the widespread adoption of advanced technologies in the manufacturing process of generic injectables is propelling the market growth in the US.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the US generic injectables market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on therapeutic area, containers, and distribution channel.
Breakup by Therapeutic Area:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
On the basis of the therapeutic area, the market has been segmented into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular.
Breakup by Containers:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Based on the containers, the market has been bifurcated into vials, ampoules, premix, and prefilled syringes.
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
On the basis of the distribution channel, the market has been classified into hospitals and retail pharmacies.
Competitive Landscape:
The market is highly concentrated in nature with the presence of only a few top manufacturers who compete against one another in terms of prices and quality.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Therapeutic Area, Containers, Distribution Channel |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.2.1 Sales Volume
5.2.2 Sales Value
5.3 Market Breakup by Country
5.4 Market Forecast
6 US Generic Drug Industry
6.1 Market Overview
6.2 Market Performance
6.2.1 Sales Volume
6.2.2 Sales Value
6.3 Market Forecast
7 US Generic Drug Industry – Drug Delivery Systems
7.1 Orals
7.2 Injectables
7.3 Dermal/Topical
7.4 Inhalers
8 Global Generic Injectables Industry
8.1 Market Overview
8.2 Market Performance
8.3 Market Breakup by Region
8.4 Market Breakup by Therapeutic Area
8.5 Market Breakup by Containers
8.6 Market Breakup by Distribution Channel
8.7 Market Share of Key Players
8.8 Market Forecast
9 US Generic Injectables Industry
9.1 Market Overview
9.2 Market Performance
9.3 Impact of COVID-19
9.4 Market by Therapeutic Area
9.5 Market by Containers
9.6 Market by Distribution Channel
9.7 Market Share of Key Players
9.8 Market Forecast
9.9 SWOT Analysis
9.9.1 Overview
9.9.2 Strengths
9.9.3 Weaknesses
9.9.4 Opportunities
9.9.5 Threats
9.10 Value Chain Analysis
9.11 Porters Five Forces Analysis
9.11.1 Overview
9.11.2 Bargaining Power of Buyers
9.11.3 Bargaining Power of Suppliers
9.11.4 Degree of Rivalry
9.11.5 Threat of New Entrants
9.11.6 Threat of Substitutes
9.12 Key Success and Risk Factors
10 US Generic Injectables Market: Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Anesthesia
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Anti-Infectives
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Parenteral Nutrition
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Cardiovascular
10.5.1 Market Trends
10.5.2 Market Forecast
11 US Generic Injectables Market: Breakup by Containers
11.1 Vials
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ampoules
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Premix
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Prefilled Syringes
11.4.1 Market Trends
11.4.2 Market Forecast
12 US Generic Injectables Market: Breakup by Distribution Channel
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Retail Pharmacy
12.2.1 Market Trends
12.2.2 Market Forecast
13 US Generic Injectables Market: Competitive Landscape
13.1 Competitive Structure
13.2 Market Breakup by Key Players
14 Generic Injectables Manufacturing Process
14.1 Product Overview
14.2 Detailed Process Flow
14.3 Various Types of Unit Operations Involved
14.4 Mass Balance and Raw Material Requirements
15 Project Details, Requirements and Costs Involved
15.1 Land, Location and Site Development
15.2 Construction Requirements
15.3 Machinery Requirements
15.4 Machinery Pictures
15.5 Raw Materials Requirements
15.6 Raw Material and Final Product Pictures
15.7 Packaging Requirements
15.8 Transportation Requirements
15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16 Key Player Profiles
List of Figures
Figure 1: Global: Generic Drug Market: Sale Volume (in Billion Standard Units), 2016-2021
Figure 2: Global: Generic Drug Market: Sale Value (in Billion US$), 2016-2021
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2021
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2021
Figure 5: Global: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2022-2027
Figure 6: Global: Generic Drug Market Forecast: Sale Value (in Billion US$), 2022-2027
Figure 7: US: Generic Drug Market: Sale Volume (in Billion Standard Units), 2016-2021
Figure 8: US: Generic Drug Market: Sale Value (in Billion US$), 2016-2021
Figure 9: US: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2022-2027
Figure 10: US: Generic Drug Market Forecast: Sale Value (in Billion US$), 2022-2027
Figure 11: US: Generic Drug Market: Drug Delivery Systems (in %), 2021
Figure 12: Global: Generic Injectables Market: Sale Value (in Billion US$), 2016-2021
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2021
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
Figure 15: Global: Generic Injectables Market: Breakup by Containers (in %), 2021
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2021
Figure 18: Global: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2022-2027
Figure 19: US: Generic Injectables Market: Sale Value (in Billion US$), 2016-2021
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
Figure 21: US: Generic Injectables Market: Breakup by Containers (in %), 2021
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
Figure 23: US: Generic Injectables Market: Breakup by Key Players (in %), 2021
Figure 24: US: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2022-2027
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 28: US: Generic Injectables (Oncology) Market: Sale Value (in Million US$), 2016 & 2021
Figure 29: US: Generic Injectables (Oncology) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 30: US: Generic Injectables (Anesthesia) Market: Sale Value (in Million US$), 2016 & 2021
Figure 31: US: Generic Injectables (Anesthesia) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 32: US: Generic Injectables (Anti-Infectives) Market: Sale Value (in Million US$), 2016 & 2021
Figure 33: US: Generic Injectables (Anti-Infectives) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 34: US: Generic Injectables (Parenteral Nutrition) Market: Sale Value (in Million US$), 2016 & 2021
Figure 35: US: Generic Injectables (Parenteral Nutrition) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 36: US: Generic Injectables (Cardiovascular) Market: Sale Value (in Million US$), 2016 & 2021
Figure 37: US: Generic Injectables (Cardiovascular) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 38: US: Generic Injectables (Vials) Market: Sale Value (in Million US$), 2016 & 2021
Figure 39: US: Generic Injectables (Vials) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 40: US: Generic Injectables (Ampoules) Market: Sale Value (in Million US$), 2016 & 2021
Figure 41: US: Generic Injectables (Ampoules) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 42: US: Generic Injectables (Premix) Market: Sale Value (in Million US$), 2016 & 2021
Figure 43: US: Generic Injectables (Premix) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 44: US: Generic Injectables (Prefilled Syringes) Market: Sale Value (in Million US$), 2016 & 2021
Figure 45: US: Generic Injectables (Prefilled Syringes) Market Forecast: Sale Value (in Million US$), 2022-2027
Figure 46: US: Generic Injectables Market: Sales through Hospitals (in Million US$), 2016 & 2021
Figure 47: US: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2022-2027
Figure 48: US: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2016 & 2021
Figure 49: US: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2022-2027
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing Process: Conversion Rate of Feedstock
Figure 52: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 53: Generic Injectables Manufacturing: Profit Margins at Various Levels of the Supply Chain
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2021 and 2027
Table 2: US: Generic Drug Market: Key Industry Highlights, 2021 and 2027
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 6: US: Generic Injectables Market Forecast: Breakup by Containers (in Million US$), 2022-2027
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 8: US: Generic Injectables Market: Competitive Structure
Table 9: US: Generic Injectables Market: Key Players
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Civil Works
Table 12: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit
Table 13: Generic Injectables Manufacturing Plant: Raw Material Requirements